| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |